Dusseldorf - Delayed Quote EUR
CytomX Therapeutics Inc (6C1.DU)
1.8920
+0.0940
+(5.23%)
At close: May 16 at 7:31:54 PM GMT+2
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6C1.DU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 5/15/2025 |
| Upgrade | HC Wainwright & Co.: Neutral to Buy | 5/15/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 4/14/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/7/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 1/7/2025 |
| Reiterates | HC Wainwright & Co.: Neutral | 11/11/2024 |
Related Tickers
N04.SG Nucana PLC (ADRs)
0.0320
+3.23%
N04.MU Nucana PLC R
0.0475
+6.74%
N04.BE Nucana PLC R
0.0825
-2.37%
N04.F NuCana plc
0.0390
+30.00%
2LB.BE Iovance Biotherapeutics Inc
1.5646
+4.06%
NXTC NextCure, Inc.
0.4380
+5.98%
ASMB Assembly Biosciences, Inc.
13.42
+7.36%
REVB Revelation Biosciences, Inc.
3.0500
-0.97%
GLYC GlycoMimetics, Inc.
0.2470
-1.12%
GLPG.AS Galapagos NV
24.40
+2.01%